We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
Add this topic to your myFT Digest for news straight to your inbox
Case is among several announced on Tuesday over alleged crimes including export violations and smuggling
Group will work with Interpol and Europol to crack down on illegal streaming of sporting events
Brussels’ new rules on compulsory licences at home could influence battles over drug patents overseas
Supply chain disruptions highlight an increasingly complex east-west interdependency
British pop star cleared of claims he copied elements of Marvin Gaye song with his hit ‘Thinking Out Loud’
Led by Huawei, Chinese groups are filing patents around the tech that enables products to access the internet
Intellectual property laws cannot handle possibility artificial intelligence could invent things on its own
UK’s largest supermarket may have to cease using current design after it was judged too similar to that of rival
The question of who should tweak works, and when, baffles fans and authors alike
Industry rejects call for transparency over use of strategy that can delay competition from generic medicines
Specialist drugs sold by Big Pharma are so expensive that many patients are being excluded
Role-playing games like Dungeons & Dragons are having a moment in the spotlight – and offer valuable lessons to the rest of the economy
Manufacturers showed during the pandemic that they can deliver low-cost treatments at scale
New York jury rejected artist’s claim that digital depictions of luxury bags was legally protected expression
Apply for the 2023 ranking, and read last year’s coverage
Clients and peers are invited to recommend firms and rate them for specialist expertise
Amgen to launch ‘biosimilar’ version of medicine that has generated $200bn in sales since launch
Millions of pounds are being invested to turn scientific research into global companies. But some founders say they have to give up too much equity
Platform aims to increase transparency on provenance of pieces from smaller makers, boosting resale potential
Getty Images and others are challenging AI companies’ use of copyrighted images to train their image-generating algorithms
Skynet hits the books
Bloc asks global body to convene panels to rule on two trade disputes
Ending of pharma group’s IP truce spells fight for future of mRNA technology
Pharma company still ‘eager’ to collaborate with Beijing, despite collapse of initial talks
Lawsuit centres on US company’s purchase of start-up Nuvia
International Edition
